Cytosorbents (CTSO) Enterprise Value (2010 - 2026)
Cytosorbents (CTSO) reported Enterprise Value of -$4.8 million for Q1 2026, up 63.39% on a YoY basis from -$2.9 million in Q1 2025, and up 23.19% quarter-over-quarter from -$6.2 million in Q4 2025.
Cytosorbents (CTSO) Enterprise Value (2010 - 2026) Analysis & Trends
Cytosorbents has reported Enterprise Value for 17 years, with the latest figure at -$4.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 63.39% year-over-year to -$4.8 million; the trailing twelve-month figure through Mar 2026 stood at -$4.8 million (up 63.39% YoY), and the FY2025 full-year result was -$6.2 million, up 57.67% from the prior year.
- Enterprise Value for Q1 2026 stood at -$4.8 million, up from -$6.2 million in the prior quarter.
- The five-year high for Enterprise Value was -$4.8 million in Q1 2026, with the low at -$43.0 million in Q1 2022.
- Historically, Enterprise Value has averaged -$14.8 million across 5 years, with a median of -$13.1 million in 2025.
- Annual changes were most pronounced in 2025 — Enterprise Value plunged 56.98% — and 2026, when it soared 63.39%.
- Cytosorbents' Enterprise Value stood at -$22.1 million in 2022, then jumped by 36.19% to -$14.1 million in 2023, then fell by 4.48% to -$14.8 million in 2024, then surged by 57.67% to -$6.2 million in 2025, then grew by 23.19% to -$4.8 million in 2026.
- The last three Enterprise Value figures came in at -$4.8 million (Q1 2026), -$6.2 million (Q4 2025), and -$7.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -8.17 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -3.09 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -426.00 Mn |
| 10 | Cytosorbents | 28.80 Mn | 24.00 Mn | 6.13 Mn | -4.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.80 Mn |
| Dec 31, 2025 | -6.25 Mn |
| Sep 30, 2025 | -7.54 Mn |
| Jun 30, 2025 | -10.20 Mn |
| Mar 31, 2025 | -13.11 Mn |
| Dec 31, 2024 | -14.76 Mn |
| Sep 30, 2024 | -6.50 Mn |
| Jun 30, 2024 | -6.50 Mn |
| Mar 31, 2024 | -8.61 Mn |
| Dec 31, 2023 | -14.13 Mn |
| Sep 30, 2023 | -8.40 Mn |
| Jun 30, 2023 | -13.20 Mn |
| Mar 31, 2023 | -19.05 Mn |
| Dec 31, 2022 | -22.14 Mn |
| Sep 30, 2022 | -22.55 Mn |
| Jun 30, 2022 | -30.16 Mn |
| Mar 31, 2022 | -43.02 Mn |
| Dec 31, 2021 | -52.14 Mn |
| Sep 30, 2021 | -61.04 Mn |
| Jun 30, 2021 | -65.61 Mn |